Boardroom Alpha
Boardroom Alpha
IEX · Current Report (Form 8-K) · Filed December 4, 2025

Idex Corp — Current Report (Form 8-K)

Form
8-K
Filed
December 4, 2025
Period
Dec 1, 2025
Ticker
IEX
Accession
0001193125-25-308187
Boardroom Alpha · Filing insights

IDEX appoints Sean Gillen as CFO effective Jan 5, 2026; CHRO Melissa Flores resigns effective Dec 19, 2025.

About Idex Corp
Market cap
$17.0B
1Y TSR
+46.0%
3Y TSR
+3.2%
Board grade
C
Sector
Industrials
CEO
Eric D Ashleman
Last annual meeting: May 6, 2026 · View full Idex Corp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report: December 1, 2025

(Date of earliest event reported)

 

 

IDEX CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-10235   36-3555336
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

3100 Sanders Road, Suite 301

Northbrook, Illinois 60062

(Address of principal executive offices, including zip code)

(847) 498-7070

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, par value $.01 per share   IEX   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02 – Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

Appointment of Chief Financial Officer

On December 4, 2025, IDEX Corporation (the “Company”) announced the appointment of Sean M. Gillen as Senior Vice President and Chief Financial Officer of the Company, effective January 5, 2026. In connection with his appointment, on January 5, 2026, Akhil Mahendra, will cease serving as Interim Chief Financial Officer and will continue serving as the Company’s Vice President, Corporate Development.

Mr. Gillen, age 40, is joining the Company from AAR CORP. (NYSE: AIR), a provider of aviation services to the aerospace and defense industries, where he has served as Senior Vice President and Chief Financial Officer since January 2019. Prior to joining AAR CORP., Mr. Gillen was Vice President and Treasurer of USG Corporation, a building materials manufacturing company, since 2017. Prior to USG Corporation, Mr. Gillen spent nine years in investment banking with Goldman Sachs, most recently as a Vice President in its Global Industrial Investment Banking Division. Mr. Gillen received a Bachelor of Business Administration from the University of Michigan.

There are no arrangements or understandings between Mr. Gillen and any other person pursuant to which he was appointed as the Company’s Senior Vice President and Chief Financial Officer. Mr. Gillen does not have any family relationship with any director or other executive officer of the Company, and there are no transactions in which Mr. Gillen has an interest requiring disclosure under Item 404(a) of Regulation S-K.

In connection with Mr. Gillen’s appointment as Senior Vice President and Chief Financial Officer, the Company entered into an offer letter with Mr. Gillen on December 1, 2025 (the “Offer Letter”). Under the terms of the Offer Letter, Mr. Gillen will receive an initial base salary of $625,000 and, beginning with the Company’s 2026 incentive program, will have a target opportunity under the Company’s Management Incentive Compensation Plan equal to 85% of his base salary and will be eligible for an annual equity grant with a targeted grant date fair value of $2,000,000. In connection with the commencement of his employment with the Company, Mr. Gillen will receive a new hire restricted stock award with a grant date fair value of $3,000,000, vesting in one-third installments on each anniversary of the grant date. Mr. Gillen will also receive a cash sign-on bonus of $325,000, which is subject to repayment if he leaves the Company or is terminated for cause prior to the 12-month anniversary of his start date. The Offer Letter also provides for severance benefits equal to 12 months of base salary and Mr. Gillen’s target annual incentive in the event his employment is terminated by the Company without cause, with such severance benefits increasing to two times his base salary and target annual incentive in the event he is terminated by the Company without cause within 24 months following a change in control of the Company. As a condition to his employment, Mr. Gillen will also be subject to a Confidential Information, Work Product and Restrictive Covenant Agreement, which includes, among other items, non-competition and non-solicitation restrictive covenants.

Departure of Senior Vice President and Chief Human Resources Officer

On December 1, 2025, Melissa S. Flores, Senior Vice President and Chief Human Resources Officer of the Company and a current named executive officer of the Company, notified the Company of her decision to resign, effective December 19, 2025, to pursue another employment opportunity.

Item 7.01 – Regulation FD Disclosure.

On December 4, 2025, the Company issued a press release announcing Mr. Gillen’s appointment and Ms. Flores’ departure. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 7.01 is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 – Financial Statements and Exhibits.

(d) Exhibits

 

99.1

Press release dated December 4, 2025.

 

104.0

Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    IDEX CORPORATION
    By:  

/s/ LISA M. ANDERSON

      Lisa M. Anderson
      Senior Vice President, General Counsel and Corporate Secretary
December 4, 2025      
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Idex Corp (IEX)

Reference

Frequently asked questions

When did Idex Corp file this 8-K?
Idex Corp (IEX) filed this Current Report (Form 8-K) with the SEC on December 4, 2025. The accession number assigned by EDGAR is 0001193125-25-308187.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
IDEX appoints Sean Gillen as CFO effective Jan 5, 2026; CHRO Melissa Flores resigns effective Dec 19, 2025. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Idex Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Idex Corp has filed under CIK 832101, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer